Substituted-1,4-diazepines

US5116971A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Albrecht Harreus · Ingelheim am Rhein, DE
• Karl-Heinz Weber · Gau-Algesheim, DE
• Werner Stransky · Gau-Algesheim, DE
• Gerhard Walther · Bingen, DE
• Gojko Muacevic · Ingelheim am Rhein, DE
• Jorge C. Stenzel · Mainz, DE
• Wolf-Dietrich Bechtel · Appenheim, DE

Key dates

• Filing date: Sep 19, 1990
• Grant date: May 26, 1992
• Expiry date: Sep 19, 2010

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D495/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to new 1,4-diazepines of the general formula ##STR1## in which R.sub.1, R.sub.2 R.sub.3, X and A have the meaning indicated in the specification. The new compounds are intended for use for the treatment of pathological states and diseases in which PAF (platelet activating factor) is involved.